The largest database of trusted experimental protocols

Ek 2110 kit

Manufactured by Hooke Laboratories
Sourced in United States

The EK-2110 kit is a laboratory equipment kit designed for general purpose experimental use. It includes essential components such as a power supply, wiring, and measurement devices. The core function of the EK-2110 kit is to provide a versatile platform for conducting various scientific experiments and measurements.

Automatically generated - may contain errors

7 protocols using ek 2110 kit

1

Induction of Experimental Autoimmune Encephalomyelitis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the age of 11 weeks, female C57BL/6 mice were actively immunized subcutaneously with 200 μg myelin oligodendrocyte glycoprotein peptide (MOG35−55) emulsified in 100 μl complete Freund's adjuvant containing 4 mg/ml Mycobacterium tuberculosis (EK-2110 kit; Hooke Laboratories, Massachusetts, USA). Directly after MOG35−55 immunization and after 24 h, mice were intraperitoneally injected with 100 ng (C57BL/6JOlaHsd donor mice adoptive T cell transfer) or 40 ng (endothelial specific knockout mice) pertussis toxin (EK-2110 kit; Hooke Laboratories) to induce a normal or a mild EAE, respectively. Both the control group and experimental group of one experiment received the same amount of PTX. Mice were weighed and clinically evaluated daily for neurological signs of the disease according to manufacturer's mouse EAE scoring guide: 0: no clinical symptoms; 0.5: distal tail paralysis; 1: tail paralysis; 2: mild paraparesis and ataxia; 2.5: moderate paraparesis; 3: complete paralysis of the hind legs; 4: paralysis to the diaphragm; 5: death by EAE.
+ Open protocol
+ Expand
2

MOG35-55 Peptide-Induced EAE Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type C57BL/6 females (11 weeks old) were subcutaneously immunized with 200 µg myelin oligodendrocyte glycoprotein (MOG35-55) peptide emulsified in 200µl complete Freund's adjuvant containing 5mg/ml Mycobacterium tuberculosis (EK-2110 kit; Hooke Laboratories, Massachusetts, USA). Directly after immunization and 24h later, mice received an intraperitoneal injection of 100ng pertussis toxin (EK-2110 kit; Hooke Laboratories). Mice were sacrificed on day 14 post immunization. Spinals cords were isolated and snap frozen for real-time quantitative PCR.
+ Open protocol
+ Expand
3

Induction of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the induction of EAE, the mouse model of MS, animals were injected subcutaneously with an emulsion of MOG35-55 peptide in complete Freud’s adjuvant (CFA; EK-2110 kit from Hooke Laboratories), followed by intraperitoneal injection with pertussis toxin in PBS (200 ng per animal) on the day of immunization and with 24 h delay (according to manufacturer’s instructions). Control animals underwent the same treatment, but CFA without MOG35-55 peptide (CK-2110 kit from Hooke Laboratories) was used instead. Spinal cord and brains were collected at the peak of the disease when clinical score 3 (representing limp tail and complete paralysis of hind legs) has been reached. Animals that did not reach this clinical score were not analyzed in this study.
+ Open protocol
+ Expand
4

Chronic EAE Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the induction of chronic EAE, animals were injected subcutaneously with an emulsion of MOG35-55 in complete Freud’s adjuvant (CFA; EK-2110 kit from Hooke Laboratories) followed by the administration of pertussis toxin in PBS (0,2μg per animal), for two consecutive days (all according to manufacturer’s instructions). Spinal cords and cerebellum were collected at the peak/chronic stage of the disease with clinical score=3 representing limp tail and complete paralysis of hind legs. Animals that did not reach this clinical score were not analyzed in this study. Additional animals were injected subcutaneously with a CFA emulsion (CK-2110 kit from Hooke Laboratories) and analyzed as controls.
+ Open protocol
+ Expand
5

Induction of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the induction of EAE, the mouse model of MS, animals were injected subcutaneously with an emulsion of MOG35-55 peptide in complete Freud’s adjuvant (CFA; EK-2110 kit from Hooke Laboratories), followed by intraperitoneal injection with pertussis toxin in PBS (200 ng per animal) on the day of immunization and with 24 h delay (according to manufacturer’s instructions). Control animals underwent the same treatment, but CFA without MOG35-55 peptide (CK-2110 kit from Hooke Laboratories) was used instead. Spinal cord and brains were collected at the peak of the disease when clinical score 3 (representing limp tail and complete paralysis of hind legs) has been reached. Animals that did not reach this clinical score were not analyzed in this study.
+ Open protocol
+ Expand
6

MOG-Induced EAE in C57BL/6 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eleven-week-old C57BL/6JOlaHsd mice were immunized subcutaneously with 200 ng of myelin oligodendrocyte glycoprotein peptide (MOG35−55) emulsified in 100 μl complete Freund’s supplemented with 4 mg/ml of Mycobacterium tuberculosis (EK2110, Hooke Laboratories). Immediately after MOG immunization and after 24 h, mice were intraperitoneally injected with 50 ng pertussis toxin (EK2110 kit, Hooke Laboratories) to induce EAE. EAE animals were treated daily with phloretin or vehicle (50 mg/kg, intraperitoneal (ip)) after 6 days of immunization (prophylactic setup) or after disease onset (clinical score > 1, therapeutic setup). Mice were weighed and scored daily for neurological signs of the disease according to the manufacturer’s mouse EAE scoring guide: 0: no clinical symptoms, 0.5: tip of tail is limp, 1: limp tail, 1.5: limp tail and hind leg inhibition 2: limp tail and weakness of hind legs, 2.5: limp tail and dragging of hind legs, 3: limp tail and complete paralysis of the hind legs, 3.5: limp tail and complete paralysis of hind legs and mouse is unable to right itself when placed on its side, 4: paralysis to the diaphragm, 5: death by EAE.
+ Open protocol
+ Expand
7

Chronic EAE Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the induction of chronic EAE, animals were injected subcutaneously with an emulsion of MOG35-55 in complete Freud’s adjuvant (CFA; EK-2110 kit from Hooke Laboratories) followed by the administration of pertussis toxin in PBS (0,2μg per animal), for two consecutive days (all according to manufacturer’s instructions). Spinal cords and cerebellum were collected at the peak/chronic stage of the disease with clinical score=3 representing limp tail and complete paralysis of hind legs. Animals that did not reach this clinical score were not analyzed in this study. Additional animals were injected subcutaneously with a CFA emulsion (CK-2110 kit from Hooke Laboratories) and analyzed as controls.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!